Orlistat Ip/bp/usp/ep Cas No: 96829-58-2

Niksan Pharmaceutical is top leading manufacturer, supplier, exporter and trader in Indian states and also in world other countries. Orlistat is the best product of Niksan Pharmaceutical which exporting as a form of API and finished formulation.

Niksan Pharmaceutical is the supplier, manufacturer, exporter and trader in the domestic level as well as the international market.

Niksan is an Indian based pharmaceutical company so it also supply and manufacture the Orlistat to all Indian states like Andhra Pradesh, Jammu & Kashmir, Punjab, Delhi, Maharashtra, Karnataka, Chandigarh, Gujarat, Tamil Nadu, Haryana, West Bengal, Telangana, Kerala, Uttar Pradesh, Rajasthan, Madhya Pradesh, Bihar and many other states of India.

Niksan pharmaceutical and Niksan group companies are exporter, supplier and manufacturer of the API and also Orlistat formulations in many countries for many years. Niksan pharmaceutical currently exports Orlistat API and Formulation to countries like Mexico, Brazil, Colombia, Chile, Venezuela, Dominican Republic, Ecuador, Paraguay, Lebanon, United Kingdom, Bolivia, Argentina, Panama, Peru, Uruguay, Philippines, Pakistan, Guatemala, Costa Rica, Iraq, Spain, Germany, Belgium, Malaysia, Czechia, United Arab Emirates, Egypt, Nigeria, Bangladesh, Switzerland, Italy, Denmark, Vietnam, Ireland, United States, Portugal, Austria, Singapore, Australia, Finland, Saudi Arabia, Canada, Poland, South Africa, Indonesia, Sweden, Netherlands, Romania, Taiwan, France, Turkey, Thailand, Iran, Japan and many other countries.

Orlistat is used to treatment of obesity.

SYNONYMS: Orlipastat, Orlipastatum, Orlistat, Tetrahydrolipstatin

IUPAC NAME: (2S)-1-[(2S, 3S)-3-hexyl-4-oxooxetan-2-yl] tridecan-2-yl (2S)-2-formamido-4-methylpentanoate

CAS NO: 96829-58-2

FORMULA: C29H53NO5

MOLECULAR MASS: 495.73 g/mol

STORAGE OF ORLISTAT: Store it in cool and dry place, away from moisture and direct light. Keep away from children or pets. Do not store this medicine in bathroom and kitchen or any humidly place.

APPLICATIONS OF ORLISTAT: Orlistat is used to control your diet plan and help you in lose weight. Orlistat is also used to treatment of behaviour changes and reduce-calorie.

HOW TO USE: Orlistat is distributed as a capsule form so you can take it by mouth with or without food. Take Orlistat before meal or 1 hour after meal.

HOW ORLISTATWORKS: Orlistat breaks down fat in your diet by blocking enzymes.

CONTRAINDICATIONS: Kindly avoid this tablet if you have anorexia nervosa, Bulimia or liver tissue death. If you are patent of liver damage or liver failure kindly avoid Orlistat medication. Do not take Orlistat if you have high amount of oxalic acid in your urine. If you have low thyroid hormone level in your body kindly avoid Orlistat drug. Do not take Orlistat during pregnancy. If you have allergic to Orlistat tell your doctor before taking medication.

PHARMACOKINETICS OF ORLISTAT: Systemic absorption of Orlistat is minimal after the administration. Half life is approximately 1 to 2 hour after administration. 99% Orlistat drug bound to plasma proteins. Time of peak plasma concentration is 8 hour and peak plasma concentration is less than 5 mg/ml. Orlistat largely eliminated by feces.

SIDE EFFECTS OF ORLISTAT: Most common side effects of Orlistat are loose stools
Clay-collared stools, Diarrhea, Rectal pain, Nausea, Vomiting and Stomach pain. Weaknesses, Dark urine, Itching, Loss of appetite, yellowing of the skin or eyes are other side effects of Orlistat. In the rare case patient may see Headache, Back pain, Skin rash and cough.

PRECAUTIONS: Orlistat may improve your blood sugar if you have diabetes or weight loss problem. So kindly avoid Orlistat. Must be not used Orlistat during pregnancy because Orlistat may affect on unborn baby. This medication may increased the risk of kidney stone so kindly avoid Orlistat if not clearly needed. Discuss with your doctor before taking this medication.

CDSCO APPROVAL: Orlistat 120mg capsule is approved by CDSCO in India in 22.08.2007.
Orlistat capsule is approved by CDSCO in India in 01.06.2009.
Orlistate capsule is approved by CDSCO in India in 27.10.2004.

FORMULATIONS AVAILABLE IN MARKET:
Orlistat 60 MG capsules
Orlistat 120 MG capsules

Note: Product protected by valid patents are not offered for sale in countries where such patents are still valid and its liability is at Buyers Risk.

REFERENCES:

www.webmd.com
https://pubchem.ncbi.nlm.nih.gov
https://go.drugbank.com
https://cdscoonline.gov.in
https://www.wikipedia.org/
https://www.drugs.com
https://www.zaubacorp.com
https://www.practo.com/consult